The Data Leader’s Role in Measuring and Communicating the Value of Real-world Data

Real-world data have become an essential resource for life sciences companies working across the product life cycle. But, mounting financial pressures in the industry have led to heightened scrutiny around these investments. The difficulty that many organizations face in effectively communicating the impact of these data and their outputs only compounds the problem.

It is crucial for leaders to articulate the value of these data across the enterprise, demonstrating their impact on the business and advocating for continued investment. With industry dynamics such as evolving regulatory requirements, highly competitive therapeutic markets and the rise of precision medicine, data and evidence are more crucial than ever before to produce high-quality research and meet organizational goals.

In this webinar, speakers specializing in real-world evidence will discuss the current challenges and opportunities in determining the value of real-world data. They will explore strategies for framing the value narrative within an organization and provide vital insights for success.

Register for this webinar today to gain insights into how to effectively communicate the value of real-world data investments across biopharmaceutical organizations.

Speakers

Eric Fontana, Vice President, Client Solutions, Real-World Data and Analytics, Optum Life Sciences

Eric Fontana leads a diverse team of Clinicians, Analysts and Data Scientists that serve as frontline support for life sciences organizations employing Optum’s real world-data assets. Eric’s entire professional career has been in health care, starting in clinical practice as an Osteopath in Australia, followed by a 15-year run with the Advisory Board Company, where he led a variety of research and analytic functions in support of care delivery at virtually every level of provider-side health care, including major IDNs, community hospitals and independent group practices.

Message Presenter

Ami Buikema, MPH, Vice President, HEOR Research, Consulting and Client Engagement, Optum Life Sciences

Ami Buikema supports research design and innovation across all therapeutic areas. She is passionate about providing high-quality research solutions for life sciences organizations. She earned her Master of Public Health in epidemiology from the University of Minnesota and has authored and co-authored publications appearing in numerous journals, including Journal of the American Medical Association and Hepatology.

Message Presenter

Liz Poole, PhD, Head, Real-World Evidence, Epidemiology, Medical Affairs and Value Statistics (REM), Jazz Pharmaceuticals

Liz leads the Real-World Evidence, Epidemiology, and Medical Affairs Statistics team at Jazz Pharmaceuticals, which she joined in 2022. Prior to Jazz, she had a variety of RWE and statistics roles at Bluebird Bio and Sanofi. Liz was previously on the faculty at Harvard Medical School, conducting research in the Nurses’ Health Study cohorts. She has a PhD in epidemiology from the University of Washington.

Message Presenter